These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2524847)

  • 1. Photosensitization tissue model.
    Schifano MJ; Grossweiner LI
    Photochem Photobiol; 1989 Apr; 49(4):401-5. PubMed ID: 2524847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of medium polarity on the photosensitizing properties of hematoporphyrin and hematoporphyrin derivative (Photofrin II).
    Shopova M; Gantchev T
    J Photochem Photobiol B; 1988 Nov; 2(3):365-71. PubMed ID: 2853216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
    Winther JB
    Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas.
    Gibson SL; Murant RS; Hilf R
    Cancer Res; 1988 Jun; 48(12):3360-6. PubMed ID: 2836053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy of human bladder cancer cells in vitro correlated with cellular fluorescence levels of Photofrin-II.
    Williams RD; Runge TC
    Photochem Photobiol; 1987 Nov; 46(5):733-7. PubMed ID: 2964661
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man.
    Gilson D; Ash D; Driver I; Feather JW; Brown S
    Br J Cancer; 1988 Nov; 58(5):665-7. PubMed ID: 2975499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Photodynamic destruction of in vitro cultivated squamous cell carcinoma cells of the head and neck area].
    Wustrow TP; Jocham D; Schramm A; Unsöld E
    Laryngol Rhinol Otol (Stuttg); 1988 Oct; 67(10):532-8. PubMed ID: 2976868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response.
    Fingar VH; Henderson BW
    Photochem Photobiol; 1987 Nov; 46(5):837-41. PubMed ID: 2964665
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison on the biological activity of three home-made HpDs with that of photofrin II].
    Han R; Xu CX; Li ZR; Cheng YS; Du CZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):159-64. PubMed ID: 2946453
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
    Gibson SL; van der Meid KR; Murant RS; Hilf R
    Br J Cancer; 1990 Apr; 61(4):553-7. PubMed ID: 2139578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of indium 111-labeled dihematoporphyrin ether in papillomas and body tissues. Relevance to photodynamic therapy.
    Shikowitz MJ; Galli R; Bandyopadhyay D; Hoory S
    Arch Otolaryngol Head Neck Surg; 1989 Jul; 115(7):845-7. PubMed ID: 2525396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RE: Complications of whole bladder dihematoporphyrin ether photodynamic therapy.
    J Urol; 1990 Sep; 144(3):750-1. PubMed ID: 2143790
    [No Abstract]   [Full Text] [Related]  

  • 13. Dosimetry methods in photoradiation therapy.
    Profio AE; Wudl LR; Sarnaik J
    Adv Exp Med Biol; 1985; 193():35-41. PubMed ID: 2937269
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro photosensitization of human head and neck squamous cancer cells by dihematoporphyrin-ether.
    Sprik SA; Sullivan MJ; Carey TE
    Otolaryngol Head Neck Surg; 1988 Jul; 99(1):28-37. PubMed ID: 2971911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of laser photodynamic therapy on tumor phosphate levels and pH assessed by 31P-NMR spectroscopy.
    Gibson SL; Ceckler TL; Bryant TG; Hilf R
    Cancer Biochem Biophys; 1989 Oct; 10(4):319-28. PubMed ID: 2533522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The photodynamic effects of photofrin II, hematoporphyrin derivative, hematoporphyrin, and tetrasodium-mesotetra(4-sulfonatophenyl)porphine in vitro: clonogenic cell survival and drug uptake studies.
    West CM; Moore JV
    Photochem Photobiol; 1989 Feb; 49(2):169-74. PubMed ID: 2523543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cell photosensitivity following porphyrin photodynamic therapy.
    Gomer CJ; Rucker N; Murphree AL
    Cancer Res; 1988 Aug; 48(16):4539-42. PubMed ID: 2969280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picosecond fluorescence of R3230AC mammary carcinoma mitochondria after treatment with hematoporphyrin derivative and Photofrin II in vivo.
    Hanzlik CA; Knox RS; Gibson SL; Hilf R
    Photochem Photobiol; 1989 Jul; 50(1):45-53. PubMed ID: 2527374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Photodynamic action of two hematoporphyrin derivatives on transport and intracellular metabolism of adenosine in hepatoma cells].
    Fu NW; Quan LP; Zhang LS
    Zhongguo Yao Li Xue Bao; 1987 Nov; 8(6):551-4. PubMed ID: 2967620
    [No Abstract]   [Full Text] [Related]  

  • 20. Photodynamic therapy in the treatment of pancreatic carcinoma: dihematoporphyrin ether uptake and photobleaching kinetics.
    Mang TS; Wieman TJ
    Photochem Photobiol; 1987 Nov; 46(5):853-8. PubMed ID: 2964666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.